September 18, 2008 – Nucletron has created a strategic partnership with BrachySolutions to jointly expand the adoption of High Dose Rate (HDR) brachytherapy.
Through this partnership, radiation oncology centers in North America will reportedly have access to clinical best practices and a team of brachytherapy experts available to assist centers in adapting brachytherapy technologies.
Both companies also plan to leverage the deployment of Oncentra Brachy, reportedly the first fully DICOM-compatible treatment planning solution for brachytherapy, recently launched by Nucletron, as a strategic platform to optimize clinical workflows and patient outcomes.
Nulcetron and BrachySolutions plan to initiate strategic projects and joint marketing programs that incorporate the capabilities of both companies.
Representatives will be on hand to discuss this strategic partnership at ASTRO 2008.